Dermatomyositis Not Yet Recruiting Phase 1 / 2 Trials for Denosumab (DB06643)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02418273Denosumab for Glucocorticoid-treated Children With Rheumatic DisordersTreatment